Soiken Holdings Inc.
Notice of Change in Reported Segments
Announces restructuring of the business portfolio and changes to reported segments. Positions Health Care Platform as the core, renaming the Corporate Health Care Support business. Integrates cosmetics and functional materials development into Japan Preventive Medicine Co., Ltd. to form a comprehensive health care platform. The new segment will be applied from the first quarter of the fiscal year ending June 2027.
Key Figures
- New Reported Segment Name: Health Care Platform Business
- Name Change: Health Care Support Business → Corporate Health Care Support Business
- Application Timing: First quarter of the fiscal year ending June 2027
AI要約
Background and Purpose of the Change
Soeiken Holdings has been reviewing its business portfolio and pursuing organizational restructuring to realize a self-medication society and promote medical DX. This time, the five existing businesses are reorganized, consolidating three into Japan Preventive Medicine Co., Ltd., and integrating health supplements, cosmetics, and functional materials development into Japan Preventive Medicine Co., Ltd. to build a comprehensive health care platform. The new segment is named 'Health Care Platform Business', and the Health Care Support segment will be renamed to 'Corporate Health Care Support Business'.
Outlook and Specific Initiatives
The newly established Health Care Platform will, starting from self-medication e-commerce as an entry point, gradually expand services that connect 'prevention to treatment' such as OTC medicines, traditional Chinese medicines, postal testing, online medical consultation, and online pharmacies. Through OEM and functional materials development domestically and internationally, and expanding EC sites and customer base, products will be marketed in domestic and international markets. In the future, the new areas will be expanded sequentially.
総医研ホールディングス
Company overview · Stock price · Financial data · All IR
